The amount of neoantigen expressed in each tumor cell varies greatly, and LV proviruses are susceptible to silencing after incorporation into the genome (this depends greatly on the promoters; CMV, sv40, and other viral promoters are prone to silencing compared with non-viral UBC and PGK). The gene discussed is PRKG1; the disease is neoplasm.